Alemtuzumab Induction Therapy in Elderly Kidney Transplant Recipients.

被引：0
|
作者：
Yakubu, I. [1 ]
Masters, B. [1 ]
Ravichandran, B. [1 ]
Sparkes, T. [1 ]
Moss, M. [1 ]
Rasetto, F. [1 ]
Jonchhe, S. [1 ]
Thomas, B. [2 ]
Costa, N. [2 ]
Leeser, D. [2 ]
Bartlett, S. [2 ]
Haririan, A. [2 ]
机构：
[1] Univ Maryland, Med Ctr, Pharm, Baltimore, MD 21201 USA
[2] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C38
引用
收藏
页码：613 / 614
页数：2
相关论文
共 50 条
  • [41] Use of Thymoglobulin in Low Dose Schemes as Induction Therapy in High Risk Kidney Transplant Recipients.
    Perez-Vega, D.
    Rojas-Campos, E.
    Salvador, M. -C.
    Evangelista-Carrillo, L.
    Molina-Ruiz, F.
    Gomez-Navarro, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 318 - 318
  • [42] Immunosuppressive Therapy for Elderly Kidney Transplant Recipients
    Iwamoto, H.
    Nakamura, Y.
    Konno, O.
    Tomita, K.
    Ueno, T.
    Yokoyama, T.
    Kihara, Y.
    Kawachi, S.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (03) : 799 - 801
  • [43] Haematological Autoimmune Disorders Associated with Alemtuzumab Induction in Renal and Simultaneous Pancreas and Kidney Recipients.
    Kousios, A.
    Charif, R.
    Atta, M.
    Luqmani, A.
    Cooper, N.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 523 - 523
  • [44] A Steroid-Free Regime With Alemtuzumab Induction Significantly Reduced Acute Rejection Rate in Simultaneous Pancreas Kidney Transplant Recipients.
    Bank, J.
    Mallat, M.
    van der Boog, P.
    Braat, A.
    Ringers, J.
    Reinders, M.
    de Fijter, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 855 - 855
  • [45] A Steroid-Free Regime With Alemtuzumab Induction Significantly Reduced Acute Rejection Rate in Simultaneous Pancreas Kidney Transplant Recipients.
    Bank, J.
    Mallat, M.
    van der Boog, P.
    Braat, A.
    Ringers, J.
    Reinders, M.
    de Fijter, J.
    TRANSPLANTATION, 2014, 98 : 855 - 855
  • [46] Longitudinal evaluation of dd-cfDNA in elderly kidney transplant recipients.
    Samra, Manpreet
    Trotter, Christine
    Mahoney, Erin
    Mattes, Daine
    Cotiguala, Laura
    Thorndyke, Anne
    Patel, Shree
    Fu, Dennis
    Lopez-Soler, Reynold
    TRANSPLANTATION, 2024, 108 (09) : 447 - 448
  • [47] Longitudinal evaluation of dd-cfDNA in elderly kidney transplant recipients.
    Samra, Manpreet
    Trotter, Christine
    Mahoney, Erin
    Mattes, Daine
    Cotiguala, Laura
    Thorndyke, Anne
    Patel, Shree
    Fu, Dennis
    Lopez-Soler, Reynold
    TRANSPLANTATION, 2024, 108 (9S)
  • [48] Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy
    Bosch, W.
    Poowanawittayakom, N.
    Chaikriangkrai, K.
    Mendez, J.
    Hellinger, W. C.
    Gonwa, T. A.
    Krishna, M.
    Pungpapong, S.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (01) : E33 - E39
  • [49] Thymoglobulin (ATG) induction in high-risk kidney transplant recipients.
    Gurk-Turner, Cheryle
    Philosophe, Benjamin
    Airee, Richa
    Owens, Elizabeth
    Jackson, L. Andrew
    Kukuruga, Debra
    Haririan, Abdolreza
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 522 - 523
  • [50] Use of thymoglobulin for induction immunosuppression in living unrelated kidney transplant recipients.
    Wong, WC
    Agrawal, N
    Pascual, M
    DelVecchio, AM
    Doran, MT
    Anderson, D
    Hirsh, H
    Delmonico, FL
    Cosimi, AB
    Tolkoff-Rubin, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 442A - 442A
12345